Oral amodiaquine microparticles repurposed for the treatment of visceral leishmaniasis
Background: Leishmaniasis, a neglected tropical disease, is caused by parasites from the genus Leishmania and transmitted by the female phlebotamine sandfly. Visceral leishmaniasis is the systemic and most severe form of the disease, which is brought on by Leishmania donovani and Leishmania infantum...
Main Authors: | Henry Nettey, Isaac Joe Erskine, Afia Antwi Mensah, Nana Kwame Ofori Gyamera, Charles Kwadwo Obuobi, Doris Kumadoh, Isaac Julius Asiedu-Gyekye, Grace Lovia Allotey-Babington |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Scientific African |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227622001922 |
Similar Items
-
Amodiaquine hydrochloride tablets
by: 982 SIRIM -
Electrochemical and theoretical evaluation of the interaction between dna and amodiaquine: evidence of the guanine adduct formation
by: Maria Lara P. M. Arguelho, et al.
Published: (2010-01-01) -
Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo
by: Akintunde Sowunmi, et al.
Published: (2007-06-01) -
Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action
by: Vineela Parvathaneni, et al.
Published: (2022-09-01) -
Amodiaquine-Associated Asthenia: A Case Based Review and Gaps in Literature
by: Obaro Michael, et al.
Published: (2016-06-01)